Drug Profile
Measles virus vaccine live inhaled - Serum Institute of India
Alternative Names: Inhaled measles virus vaccine - Serum Institute of India/AerogenLatest Information Update: 22 Mar 2017
Price :
$50
*
At a glance
- Originator Serum Institute of India
- Class Measles vaccines; Viral vaccines; Viruses
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Measles
Most Recent Events
- 22 Mar 2017 No recent reports of development identified - Phase-III for Measles (In infants, Prevention) in India (Inhalation)
- 03 May 2011 Phase-III clinical trials in Measles in India (Inhalation)
- 01 Dec 2009 Phase-II/III clinical trials in Measles in India (Inhalation)